GlassScriptPhysician profile
Michael Blanc
NPI 1932139953
$20,805.67
in general payments reported to CMS, 2019-2025
36 companies · $2,573 in 2025
The $2,573 reported for 2025 was more than what a typical Interventional Cardiology provider received nationally (typical 2025 total: $1,092).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $8,552 · 2020: $504 · 2021: $1,010 · 2022: $1,615 · 2023: $3,816 · 2024: $2,736 · 2025: $2,573.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $6,311 · Travel and Lodging: $2,814.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $6,311.38 |
| Travel and Lodging | $2,813.83 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Bard Peripheral Vascular, INC. | $6,070.88 | 2019 | |
| Abbott Laboratories | $3,893.14 | 2019-2025 | Aveir, Coroflow, Cardiomems |
| Abiomed | $2,388.29 | 2019-2025 | Impella |
| Penumbra, INC. | $2,147.13 | 2023 | Indigo System |
| Philips North America LLC | $985.31 | 2019-2025 | (Dd1) Duo Hybrid, Coronary Other, Coronary Undivided |
| Medtronic, INC. | $706.27 | 2021-2025 | Symplicity G3, Micra, Onyx Frontier |
| Novartis Pharmaceuticals Corporation | $647.25 | 2019-2025 | |
| Astrazeneca Pharmaceuticals LP | $527.14 | 2019-2025 | Farxiga |
| Shockwave Medical, INC | $435.89 | 2021-2025 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter, Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $375.11 | 2021-2024 | Lifevest |
| Pfizer INC. | $250.20 | 2021-2025 | |
| Boston Scientific Corporation | $235.29 | 2019-2025 | Avvigo Guidance System, Latitude Communicator Power Supply |
| Amgen INC. | $229.01 | 2019-2024 | Repatha |
| Astellas Pharma US INC | $225.04 | 2019-2021 | |
| Janssen Pharmaceuticals, INC | $223.22 | 2019-2022 |
Show all 36 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Cleerly, INC. | $220.31 | 2025 | Cleerly Labs, Cleerly Ischemia |
| E.R. Squibb & Sons, L.L.C. | $194.12 | 2020-2025 | Camzyos, Eliquis |
| Merck Sharp & Dohme LLC | $187.21 | 2021-2024 | Verquvo |
| Boehringer Ingelheim Pharmaceuticals, INC. | $146.34 | 2019-2025 | Jardiance |
| Heartflow, INC. | $134.17 | 2021 | |
| Sanofi-Aventis U.S. LLC | $129.81 | 2019 | |
| Medtronic Vascular, INC. | $96.62 | 2019-2020 | |
| Tactile Systems Technology INC | $74.22 | 2019-2022 | |
| Novo Nordisk INC | $54.84 | 2022 | |
| Stryker Corporation | $37.48 | 2025 | Clottriever Bold Catheter |
| Bayer Healthcare Pharmaceuticals INC. | $24.68 | 2025 | |
| Inspire Medical Systems, INC. | $24.68 | 2025 | Inspire |
| Cardiva Medical, INC. | $22.53 | 2024 | Cardiva Vascade Mvp Vvcs 6-12f |
| Arbor Pharmaceuticals, INC. | $16.35 | 2019 | |
| United Therapeutics Corporation | $15.97 | 2020 | |
| Amarin Pharma, INC. | $15.79 | 2019 | |
| Scpharmaceuticals INC. | $15.41 | 2024 | |
| Actelion Pharmaceuticals US, INC. | $15.20 | 2019 | |
| Cardiovascular Systems INC. | $14.71 | 2019 | |
| Chiesi USA, INC. | $13.76 | 2021 | |
| Lundbeck LLC | $12.30 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michael Blanc listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.